304 related articles for article (PubMed ID: 27629750)
1. Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease.
Chang X; Wang Z; Zhang J; Yan H; Bian H; Xia M; Lin H; Jiang J; Gao X
J Transl Med; 2016 Sep; 14():266. PubMed ID: 27629750
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.
Yan HM; Xia MF; Wang Y; Chang XX; Yao XZ; Rao SX; Zeng MS; Tu YF; Feng R; Jia WP; Liu J; Deng W; Jiang JD; Gao X
PLoS One; 2015; 10(8):e0134172. PubMed ID: 26252777
[TBL] [Abstract][Full Text] [Related]
3. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
5. Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
Feng WW; Kuang SY; Tu C; Ma ZJ; Pang JY; Wang YH; Zang QC; Liu TS; Zhao YL; Xiao XH; Wang JB
Biomed Pharmacother; 2018 Mar; 99():325-333. PubMed ID: 29353208
[TBL] [Abstract][Full Text] [Related]
6. [Intervention of berberine on lipid deposition in liver cells of non-alcoholic fatty liver disease rats induced by high fat diet].
Han L; Yang QH; Zhang YP; Yan HZ; Zhu XF; Gong XW; Jin L; Wang PP; Liu YZ; Liang YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):314-9. PubMed ID: 25951637
[TBL] [Abstract][Full Text] [Related]
7. A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.
Sanyal AJ; Pacana T
Trans Am Clin Climatol Assoc; 2015; 126():271-88. PubMed ID: 26330688
[TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates nonalcoholic fatty liver disease-induced bone loss by inhibiting ferroptosis.
Gu S; Wang J; Yu S; Zhang S; Gao T; Yan D; Xie R; Gu M; Yu M; Zhang Z; Lou Z; Ding X; Chen Y; Li C
Bone; 2024 Aug; 185():117114. PubMed ID: 38723878
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism.
Yan H; Wu W; Chang X; Xia M; Ma S; Wang L; Gao J
Biol Sex Differ; 2021 Jan; 12(1):1. PubMed ID: 33397443
[TBL] [Abstract][Full Text] [Related]
10. Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers.
Sa R; Zhang W; Ge J; Wei X; Zhou Y; Landzberg DR; Wang Z; Han X; Chen L; Yin H
J Mol Cell Biol; 2016 Jun; 8(3):195-206. PubMed ID: 26993042
[TBL] [Abstract][Full Text] [Related]
11. The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease.
Zhu X; Bian H; Gao X
Molecules; 2016 Oct; 21(10):. PubMed ID: 27754444
[TBL] [Abstract][Full Text] [Related]
12. Effect of berberine and bicyclol on Chinese patients with nonalcoholic fatty liver disease: a retrospective study.
Geng Q; Zhang P; Liu X; Xue L
Postgrad Med; 2022 Jun; 134(5):507-515. PubMed ID: 35382695
[TBL] [Abstract][Full Text] [Related]
13. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
[TBL] [Abstract][Full Text] [Related]
14. [A serum lipidomic study of patients with non-alcoholic fatty liver disease].
Yang RX; Hu CX; Mi YQ; Sun WL; Chen GY; Pan Q; Shen F; Xu GW; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):122-127. PubMed ID: 28297799
[No Abstract] [Full Text] [Related]
15. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
[TBL] [Abstract][Full Text] [Related]
16. Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism.
Ma X; Yu X; Li R; Cui J; Yu H; Ren L; Jiang J; Zhang W; Wang L
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117238. PubMed ID: 37774895
[TBL] [Abstract][Full Text] [Related]
17. Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet.
Feng S; Dai Z; Liu AB; Huang J; Narsipur N; Guo G; Kong B; Reuhl K; Lu W; Luo Z; Yang CS
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1274-1284. PubMed ID: 30305244
[TBL] [Abstract][Full Text] [Related]
18. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of berberine on lipid metabolism: a new-old phytochemical with clinical applications?
Sahebkar A; Watts GF
Curr Opin Lipidol; 2017 Jun; 28(3):282-283. PubMed ID: 28459766
[No Abstract] [Full Text] [Related]
20. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
